Crossmark

Erection rehabilitation following prostatectomy — current strategies and future directions

Crossref DOI link: https://doi.org/10.1038/nrurol.2016.47

Published Online: 2016-03-15

Published Print: 2016-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sopko, Nikolai A.

Burnett, Arthur L.
License Information

Text and Data Mining valid from 2016-03-15
More Information

Article History

First Online: 15 March 2016

Competing interests

: N.A.S. declares no competing interests. A.L.B. is a consultant and/or advisor for Astellas and Genomic Health, is involved in scientific study and/or trial for Acorda Therapeutics, American Medical Systems, Auxilium, Coloplast, Endo Pharmaceuticals, Medispec, National Institutes of Health, Pfizer, Reflexonic and Vivus, is a member of the steering committee of the New England Research Institute, has a leadership position with The Center for Intimacy after Cancer Therapy, and is editorial board member forAndrology,European Urology,International Urology and Nephrology,The Journal of Sexual Medicineand Faculty Member ofPractical Reviews in Urology.